⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ITRN News
Ituran Location and Control Ltd.
Iterion Therapeutics Expands Clinical Development of Tegavivint, a First-in-Class Wnt/β-Catenin Inhibitor, into Colorectal Cancer with First Patient Dosed
prnewswire.com
ITRN
Tantalus Systems Holding Inc. Reports Fourth Quarter and Full Year 2025 Financial Results Ready to Announce with Confidence?
newsfilecorp.com
ITRN
ITURAN LOCATION AND CONTROL LTD Announces Dividend Distribution of $30 Million for the Fourth Quarter of 2025
prnewswire.com
ITRN
ITURAN PRESENTS FOURTH QUARTER & FULL YEAR 2025 RESULTS
prnewswire.com
ITRN
Tantalus Extends ERT License Agreement with Itron Ready to Announce with Confidence?
newsfilecorp.com
ITRN
Digital Utility Industry Report 2026-2035, Profiles of ABB, Accenture, Capgemini, Cisco, Cognizant, Eaton, GE, Honeywell, IBM, Itron, Microsoft, Oracle, SAP, Schneider Electric, Siemens, Toshiba
globenewswire.com
ACN
IBM
MSFT
ORCL
GE
HON
ETN
ITRN
AVGO
CTSH
Ituran Selected to Provide Full Connectivity Solution for Fiat Connect in South America
prnewswire.com
ITRN
Natural Gas Distribution Pipeline Hardware Market for Residential Application
globenewswire.com
HON
ITRN
IturanMob and Griiip to Offer Real-Time Telemetry and AI-Powered Insights to Race and Track-Day Drivers
prnewswire.com
ITRN
Iterion Therapeutics Announces First Patient Dosed in Clinical Study of Tegavivint, a First-in-Class Wnt/β-Catenin Inhibitor, in Relapsed/Refractory Osteosarcoma
prnewswire.com
ITRN